Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors

Annals of the Rheumatic Diseases

Volumn 72, Issue 5, 2013, Pages

  Ranganathan, Prabha ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NON BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUG; PENICILLAMINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

AGED; CHRONIC DISEASE; COHORT ANALYSIS; COMORBIDITY; HERPES ZOSTER; HUMAN; INCIDENCE; INFECTION RISK; KIDNEY DISEASE; LETTER; LIVER DISEASE; LUNG DISEASE; MEDICAL HISTORY; METHODOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SKIN INFECTION; SOFT TISSUE INFECTION; STEROID THERAPY; STUDY DESIGN;

ANTIRHEUMATIC AGENTS; HERPES ZOSTER; HUMANS; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS;

EID: 84875946857     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203450     Document Type: Letter

References (2)

1. Galloway JB, Mercer LK, Moseley A, et al. Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2013;72:229-34.
2. McDonald JR, Zeringue AL, Caplan L, et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis 2009;48:1364-71.